Suppr超能文献

对牛口服24毫克/千克奥立硝唑的临床安全性和驱虫效果的评估。

Evaluation of clinical safety and anthelmintic efficacy of aurixazole administed orally at 24 mg/kg in cattle.

作者信息

Sakamoto Claudio Alessandro M, Lopes Welber Daniel Zanetti, Buzzulini Carolina, Cruz Breno Cayeiro, Felippelli Gustavo, Teixeira Weslen F, Silva Helenara Machado, Santana Luis Fernando, Soares Vando Edésio, Henrique Carlos Henrique, de Oliveira Gilson Pereira, da Costa Alvimar José

机构信息

Faculdade de Ciências Agrárias e Veterinárias, UNESP/CPPAR, Via de acesso prof. Paulo Donatto Castellani, Jaboticabal, São Paulo, Brazil.

Faculdade de Ciências Agrárias e Veterinárias, UNESP/CPPAR, Via de acesso prof. Paulo Donatto Castellani, Jaboticabal, São Paulo, Brazil.

出版信息

Res Vet Sci. 2014 Jun;96(3):493-500. doi: 10.1016/j.rvsc.2014.03.007. Epub 2014 Mar 18.

Abstract

The current study evaluated, in vivo, the clinical safety and the anthelmintic efficacy of 24% aurixazole (24 mg/kg), administered orally, in bovines. Two experiments were conducted: the first one evaluating the clinical safety of 24% aurixazole (24 mg/kg) in cattle, and a second one evaluating the anthelmintic efficacy of aurixazole (24 mg/kg) against gastrointestinal nematodes on naturally infected cattle. Based on the results of clinical safety, no alterations on clinical and haematological signs and on the biochemical values obtained in animals treated orally with aurixazole 24 mg/kg were observed. Regarding the results of reduction or efficacy, obtained by eggs per gram of faeces (EPG) counts, the formulation of aurixazole reached values superior to 99% (arithmetic means) in all post-treatment dates. In two occasions, this formulation reached maximum efficacy (100%). Comparing these results with the reduction percentages obtained by EPG counts, it is possible to verify that the values obtained by all three formulations were compatible with the efficacy results. Aurixazole reached maximum efficacy (100%) against Haemonchus placei, Cooperia spatulata and Oesophagostomum radiatum. Against Cooperia punctata, this formulation reached an efficacy index of 99.99%. Regarding aurixazole, no specific trials were conducted on the field in order to evaluate the behaviour of this molecule against helminths that are resistant to other molecules, specially isolated levamisole and disophenolat. Due to this fact, future studies will be necessary to assess the effectiveness of aurixazole against strains of nematodes that are resistant to levamisole and disophenolat, but the results of clinical safety and efficacy described in this study allow us to conclude that the aurixazole molecule, concomitantly with other measures and orally administered formulations, can be another important tool in the control of nematodes parasitizing bovines.

摘要

本研究在体内评估了口服给予牛24%奥瑞硝唑(24毫克/千克)的临床安全性和驱虫效果。进行了两项实验:第一项评估24%奥瑞硝唑(24毫克/千克)对牛的临床安全性,第二项评估奥瑞硝唑(24毫克/千克)对自然感染牛胃肠道线虫的驱虫效果。基于临床安全性结果,未观察到口服24毫克/千克奥瑞硝唑的动物在临床和血液学指标以及生化值方面有任何改变。关于通过每克粪便虫卵数(EPG)计数获得的减少率或疗效结果,奥瑞硝唑制剂在所有治疗后日期的算术平均值均达到99%以上。有两次,该制剂达到了最大疗效(100%)。将这些结果与通过EPG计数获得的减少百分比进行比较,可以验证所有三种制剂获得的值与疗效结果相符。奥瑞硝唑对巴氏血矛线虫、匙形库珀线虫和辐射食道口线虫达到了最大疗效(10)。对点状库珀线虫,该制剂的疗效指数达到99.99%。关于奥瑞硝唑,尚未在田间进行专门试验以评估该分子对耐其他分子(特别是左旋咪唑和双酚酚盐)的蠕虫的作用。由于这一事实,未来有必要进行研究以评估奥瑞硝唑对耐左旋咪唑和双酚酚盐的线虫菌株的有效性,但本研究中描述的临床安全性和疗效结果使我们能够得出结论,奥瑞硝唑分子与其他措施和口服制剂一起,可以成为控制寄生在牛身上的线虫的另一个重要工具。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验